|
Jul 30
|
Avacta to Present New FAP Dox (AVA6000) Data at the European Society for Medical Oncology (ESMO) Congress
|
|
Jul 1
|
Avacta Appoints David Liebowitz, M.D., Ph.D. as Chief Medical Officer and Yulii Bogatyrenko as Advisor in Business Development
|
|
May 28
|
Avacta Therapeutics Announces Appointments of Industry Veterans to Board of Directors
|
|
Mar 10
|
Avacta Therapeutics to Present at the 2025 Leerink Global Healthcare Conference
|